Net shares · 30d
-4.7M
0 buy · 4.7M sell
Net value · 30d
-$399.7M
$0 in · $399.7M out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
1
0 buy · 4.7M sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 30d
-
SYRE Exercise·C
Director
$0
16.7K sh
Own New
-
SYRE Sell·S
Director
$399.7M
4.7M sh · $85.31
Own -100%
-
SYRE Exercise·C
Director
—
666.7K sh
Own +17%
-
JBIO Grant·A
Director, 10% Owner
$0
34.8K sh
Own New
-
APGE Grant·A
Director
$0
7.7K sh
Own New
-
ORKA Grant·A
Director, 10% Owner
$0
9.1K sh
Own New
-
CBIO Grant·A
Director, 10% Owner
$0
11.1K sh
Own New
-
SYRE Grant·A
Director
$0
8.0K sh
Own New
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | SYRE | Exercise C | 16.7K | $0 |
| Jun 23, 2026 | SYRE | Sell S | 4.7M | $399.7M |
| Jun 23, 2026 | SYRE | Exercise C | 666.7K | — |
| Jun 9, 2026 | JBIO | Grant A | 34.8K | $0 |
| Jun 9, 2026 | APGE | Grant A | 7.7K | $0 |
| Jun 2, 2026 | ORKA | Grant A | 9.1K | $0 |
| Jun 2, 2026 | CBIO | Grant A | 11.1K | $0 |
| May 27, 2026 | SYRE | Grant A | 8.0K | $0 |
Buy Sell Non-market (grant · exercise · gift)
About Fairmount Funds Management LLC
This profile aggregates every SEC Form 4 insider transaction reported by Fairmount Funds Management LLC across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.